Cargando…

Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis

Detalles Bibliográficos
Autores principales: Metz, Imke, Rieckmann, Peter, Kallmann, Boris-Alexander, Brück, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977646/
https://www.ncbi.nlm.nih.gov/pubmed/27503238
http://dx.doi.org/10.1186/s40478-016-0352-1
_version_ 1782447068011298816
author Metz, Imke
Rieckmann, Peter
Kallmann, Boris-Alexander
Brück, Wolfgang
author_facet Metz, Imke
Rieckmann, Peter
Kallmann, Boris-Alexander
Brück, Wolfgang
author_sort Metz, Imke
collection PubMed
description
format Online
Article
Text
id pubmed-4977646
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49776462016-08-10 Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis Metz, Imke Rieckmann, Peter Kallmann, Boris-Alexander Brück, Wolfgang Acta Neuropathol Commun Letter to the Editor BioMed Central 2016-08-08 /pmc/articles/PMC4977646/ /pubmed/27503238 http://dx.doi.org/10.1186/s40478-016-0352-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to the Editor
Metz, Imke
Rieckmann, Peter
Kallmann, Boris-Alexander
Brück, Wolfgang
Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
title Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
title_full Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
title_fullStr Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
title_full_unstemmed Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
title_short Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
title_sort disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977646/
https://www.ncbi.nlm.nih.gov/pubmed/27503238
http://dx.doi.org/10.1186/s40478-016-0352-1
work_keys_str_mv AT metzimke disseminatednecrotizingleukoencephalopathyeightmonthsafteralemtuzumabtreatmentformultiplesclerosis
AT rieckmannpeter disseminatednecrotizingleukoencephalopathyeightmonthsafteralemtuzumabtreatmentformultiplesclerosis
AT kallmannborisalexander disseminatednecrotizingleukoencephalopathyeightmonthsafteralemtuzumabtreatmentformultiplesclerosis
AT bruckwolfgang disseminatednecrotizingleukoencephalopathyeightmonthsafteralemtuzumabtreatmentformultiplesclerosis